文献速递技术与安全CTMR乳腺X线PET

2007至2019年诊断影像学Medicare报销趋势

Trends in Diagnostic Imaging Medicare Reimbursements: 2007 to 2019.
PubMed 文献 · J Am Coll Radiol · 2020-07-22

本研究评估2007至2019年Medicare对多种影像检查报销率的变化趋势。通过CMS医师费用表查询各影像检查的现行程序术语代码报销数据,并按2019年美元调整通胀。结果显示所有影像模态的通胀调整后报销率均下降,MRI平均降幅最大(-$52.08),骨密度检查总百分比降幅最大(-70.5%);核医学年变化(-$0.32)和总百分比变化(-4.28%)降幅最小。

要点

  • 2007至2019年,所有影像模态的通胀调整后Medicare报销率均下降。
  • MRI平均报销降幅最大(-$52.08),骨密度检查总百分比降幅最大(-70.5%)。
  • 核医学年变化(-$0.32)和总百分比变化(-4.28%)降幅最小,但个别检查除外。

核心结论

  • 2007至2019年,所有影像模态的通胀调整后Medicare报销率均下降,但核医学、X线摄影和超声的个别检查除外。
  • 鼓励进一步研究以正确建模未来报销率趋势。

研究设计与样本

  • 研究类型为报销趋势分析,未报告样本量或中心数。
  • 从CMS医师费用表查询工具提取现行程序术语代码的报销数据。
  • 纳入骨密度检查、CT、CT血管成像、乳腺X线摄影、MR血管成像、MRI、核医学、X线摄影和超声的常见诊断放射学检查。
  • 所有货币数据按通胀调整为2019年美元,并计算复合年增长率、年均变化和总百分比变化。

诊断标准与关键数值

  • MRI平均报销降幅最大,为-$52.08。
  • 骨密度检查总百分比降幅最大,为-70.5%。
  • 核医学年变化降幅最小,为-$0.32;总百分比变化降幅最小,为-4.28%。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文鼓励进一步研究以正确建模未来报销率趋势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The aim of this study was to evaluate recent trends in Medicare reimbursement rates for various imaging studies.

METHODS: Common diagnostic radiologic studies were selected across multiple imaging modalities: bone densitometry, CT, CT angiography, mammography, MR angiography, MRI, nuclear medicine, radiography, and ultrasound. The Physician Fee Schedule Look-Up Tool from CMS was queried for Current Procedural Terminology codes to extract reimbursement data. All monetary data were adjusted for inflation to 2019 US dollars. The compound annual growth rate, average annual change, and total percentage change in reimbursement were calculated on the basis of these adjusted trends.

RESULTS: Inflation-adjusted Medicare reimbursement for all imaging modalities decreased between 2007 and 2019. The greatest mean decrease in reimbursement rates was observed for MRI (-$52.08), and the largest decrease in total percentage change was seen for bone densitometry (-70.5%). Nuclear medicine demonstrated the smallest mean decreases in both annual change (-$0.32) and total percentage change (-4.28%).

CONCLUSIONS: This study examined Medicare reimbursements for radiologic studies from 2007 to 2019. After accounting for inflation, reimbursement rates were shown to decline for all studies across all imaging modalities except for individual studies in nuclear medicine, radiography, and ultrasound. Further investigation is encouraged to properly model future trends in reimbursement rates.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Kumar S, Khurana A, Haglin JM, et al. Trends in Diagnostic Imaging Medicare Reimbursements: 2007 to 2019. J Am Coll Radiol. 2020. PMID: 32710841. doi:10.1016/j.jacr.2020.07.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。